Atjaunināt sīkdatņu piekrišanu

E-grāmata: Investing in Science

(Dip Di Econ Polica E Aziendale)
  • Formāts: EPUB+DRM
  • Sērija : The MIT Press
  • Izdošanas datums: 15-Oct-2019
  • Izdevniecība: MIT Press
  • Valoda: eng
  • ISBN-13: 9780262355971
  • Formāts - EPUB+DRM
  • Cena: 55,45 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Formāts: EPUB+DRM
  • Sērija : The MIT Press
  • Izdošanas datums: 15-Oct-2019
  • Izdevniecība: MIT Press
  • Valoda: eng
  • ISBN-13: 9780262355971

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

A proposal for using cost-benefit analysis to evaluate the socioeconomic impact of public investment in large scientific projects.

A proposal for using cost-benefit analysis to evaluate the socioeconomic impact of public investment in large scientific projects.

Large particle accelerators, outer space probes, genomics platforms: all are scientific enterprises managed through the new form of the research infrastructure, in which communities of scientists collaborate across nations, universities, research institutions, and disciplines. Such large projects are often publicly funded, with no accepted way to measure the benefits to society of these investments. In this book, Massimo Florio suggests the use of cost-benefit analysis (CBA) to evaluate the socioeconomic impact of public investment in large and costly scientific projects.

The core concept of CBA of any infrastructure is to undertake the consistent intertemporal accounting of social welfare effects using the available information. Florio develops a simple framework for such accounting in the research infrastructure context and then offers a systematic analysis of the benefits in terms of the social agents involved. He measures the benefits to scientists, students, and postdoctoral researchers; the effect on firms of knowledge spillovers; the benefits to users of information technology and science-based innovation; the welfare effects on the general public of cultural services provided by RIs; and the willingness of taxpayers to fund scientific knowledge creation. Finally, Florio shows how these costs and benefits can be expressed in the form of stochastic net present value and other summary indicators.

List of Abbreviations
vii
List of Main Variables
xiii
Introduction: Beyond Big Science, the Research Infrastructure Paradigm 1(22)
1 The Evaluation Framework: A Cost-Benefit Analysis Model
23(30)
2 Costs and Financial Sustainability of Research Infrastructures
53(30)
3 Benefits to Scientists: Producing and Using Knowledge Output
83(26)
4 Students and Postdoctoral Researchers: The Effects of Research Infrastructures on Human Capital
109(22)
5 The Direct Effect on Firms: Knowledge Spillovers and Learning
131(30)
6 Benefits to Users of Information Technology in the Big Data Era
161(30)
7 Users of Science-Based Innovations
191(36)
8 Outreach and Benefits to Users of Cultural Goods
227(22)
9 Taxpayers: Science as a Global Public Good
249(24)
10 The (Expected Net Present) Value of Investing in Discovery
273(26)
Epilogue 299(6)
Acknowledgments 305(4)
Notes 309(14)
References 323(32)
Index 355